PGEN as of Oct 31 · 09:28 ET
PGENNasdaqPharmaceutical Preparations

Precigen, Inc. · Brief

Next report

4 days

Nov 4 · after closeconfirmedQ3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 7≥ implied
avg implied
±17.9%
avg realized
±11.1%
Aug 14 '24—▼−4.46%—
Nov 14 '24±21.9%▼−7.11%×0.33
Mar 19 '25±28.3%▲+0.56%×0.02
May 14 '25±14.8%▲+2.34%×0.16
Nov 13 '25±10.2%▲+25.65%×2.53
Q1 FY26±17.3%▲+25.48%×1.48
May 13 '26±12.0%▲+10.84%×0.90
Q2 FY26±21.3%▲+5.51%×0.26
quarterimplied−30%0+30%realized×
Q2 FY26±21.3%▲+5.51%×0.26
May '26±12.0%▲+10.84%×0.90
Q1 FY26±17.3%▲+25.48%×1.48
Nov '25±10.2%▲+25.65%×2.53
May '25±14.8%▲+2.34%×0.16
Mar '25±28.3%▲+0.56%×0.02
2 older reports
Nov '24±21.9%▼−7.11%×0.33
Aug '24—▼−4.46%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · confirmed

—

Linked exposure

PGEN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28report dateEarnings date confirmed: Nov 4.Source
Oct 28impliedImplied move: ±16.4% into Nov 4 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.